In this episode of Pipettes to Patients, host Dr. Brittany Simone highlights the cutting-edge breast cancer research and compassionate clinical care taking place at Upstate Medical University. Joined by cell biologist Dr. Mira Krendel and medical oncologist Dr. Sam Benjamin, the discussion explores how discoveries in the lab, such as Dr. Krendel’s work on the role of the myosin 1E gene in cancer cell movement, are advancing the understanding and treatment of breast cancer. Dr. Benjamin shares how genomic testing, immunotherapy, and targeted treatments are reshaping patient outcomes, particularly for aggressive subtypes like triple-negative breast cancer. Together, they reflect on the power of collaboration at a smaller institution like Upstate, where close connections between basic scientists and clinicians accelerate progress from bench to bedside and bring hope to patients across Central New York.